Nicole M Reilly

2PUBLICATIONS
41CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Oct 28, 2025
CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.

Bridget T Kreger, Yanke Liang, Nicole M Reilly

|Dec 14, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.

Sabrina Arena, Giorgio Corti, Erika Durinikova

Pageof 1

Frequent Collaborators

1 joint publications

Sabrina Arena

1 joint publications

Giorgio Corti

1 joint publications

Monica Montone

1 joint publications

Mariangela Russo

1 joint publications

Giuseppe Rospo

1 joint publications

Massimiliano Pagani

1 joint publications

Carola Negrino

1 joint publications

Claudio Isella

1 joint publications

Alice Bartolini

1 joint publications

Andrea Sartore-Bianchi

Frequent Collaborators

1 joint publications

Sabrina Arena

1 joint publications

Giorgio Corti

1 joint publications

Monica Montone

1 joint publications

Mariangela Russo

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma&#45;Associated Leptomeningeal Disease
06:25

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma&#45;Associated Leptomeningeal Disease

Published on : Mar 29, 2024

1.5K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.7K
See more related videos

Top Related Videos

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma&#45;Associated Leptomeningeal Disease
06:25

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma&#45;Associated Leptomeningeal Disease

Published on : Mar 29, 2024

1.5K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.7K
See more related videos